Observational studyAnnals of clinical and translational neurology2026

Annual 12-Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition.

Regina Berkovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.